Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × INDUSTRY × daromun × Clear all

Phase

Status

Unknown 2 Recruiting 2 Not yet recruiting 2 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 189 Carboplatin 132 Cisplatin 100 Paclitaxel 98 Gemcitabine 86 Pemetrexed 74 durvalumab 73 Nivolumab 68 Cyclophosphamide 55 Docetaxel 54 atezolizumab 50 Dexamethasone 46 Capecitabine 46 Bevacizumab 46 Oxaliplatin 45 130-nm albumin-bound paclitaxel 41 Lenalidomide 40 Rituximab 39 Fluorouracil 39 Fulvestrant 37 Prednisone 33 osimertinib 32 Leucovorin 30 olaparib 29 fludarabine 29 Trastuzumab 28 Doxorubicin 28 venetoclax 27 Etoposide 26 Cetuximab 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02938299 2024-09-19

Pivotal

Philogen S.p.A.

Phase 3 Active not recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡